213 related articles for article (PubMed ID: 9420050)
21. In vitro activity of meropenem compared to nine other antimicrobial agents: importance of its stability when used in agar dilution systems.
Mudaliar UA; Furyk NI; Moritz VA; Mayall BC
Pathology; 1996 Nov; 28(4):352-5. PubMed ID: 9007956
[TBL] [Abstract][Full Text] [Related]
22. Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections.
Johnson DM; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2002 May; 43(1):49-60. PubMed ID: 12052629
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial in vitro-activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics.
Lang C; Beuth J; Ko HL; Tunggal L; Pulverer G
Zentralbl Bakteriol; 1992 Dec; 277(4):485-92. PubMed ID: 1303691
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
Hata K; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1992 Sep; 36(9):1894-901. PubMed ID: 1416879
[TBL] [Abstract][Full Text] [Related]
25. In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent.
Cohen MA; Huband MD; Mailloux GB; Yoder SL; Roland GE; Domagala JM; Heifetz CL
Antimicrob Agents Chemother; 1991 Jan; 35(1):141-6. PubMed ID: 2014970
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
Fritsche TR; Stilwell MG; Jones RN
Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
[TBL] [Abstract][Full Text] [Related]
28. [In vitro antibacterial activity of meropenem, a new carbapenem: European data].
Debbia EA; Marchese A; Pesce A; Schito GC
New Microbiol; 1995 Oct; 18 Suppl():1S-17S. PubMed ID: 8574928
[TBL] [Abstract][Full Text] [Related]
29. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
30. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
Casellas JM; Tomé G; Bantar C; Bertolini P; Blázquez N; Borda N; Couto E; Cudmani N; Guerrera J; Juárez MJ; López T; Littvik A; Méndez E; Notario R; Ponce G; Quinteros M; Salamone F; Sparo M; Sutich E; Vaylet S; Wolff L
Diagn Microbiol Infect Dis; 2003 Nov; 47(3):527-37. PubMed ID: 14596972
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
Asahi Y; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
[TBL] [Abstract][Full Text] [Related]
32. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
Jones RN; Kirby JT; Rhomberg PR
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
[TBL] [Abstract][Full Text] [Related]
33. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Acred P; Ryan DM; Sowa MA; Watts CM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
Kim MY; Oh JI; Paek KS; Kim YZ; Kim IC; Kwak JH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1825-31. PubMed ID: 8843288
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
[TBL] [Abstract][Full Text] [Related]
36. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.
Watanabe N; Hiruma R; Katsu K
Antimicrob Agents Chemother; 1992 Mar; 36(3):589-97. PubMed ID: 1622167
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
Sedlock DM; Dobson RA; Deuel DM; Lesher GY; Rake JB
Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
40. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
Biedenbach DJ; Beach ML; Jones RN
Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]